Switch theme
Sign up to access all valuation multiples
SMAIO SA is engaged in offering spine surgeons a complete solution, consisting of software, implantable devices, and associated services, to treat spinal pathologies requiring surgery.
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
SMAIO has a last 12-month revenue of $7.4M and a last 12-month EBITDA of -$0.6M.
In the most recent fiscal year, SMAIO achieved revenue of $8.2M and an EBITDA of $2.2M.
SMAIO expects next 12-month revenue of XXX and NTM EBITDA of XXX
See SMAIO valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $8.2M | $5.9M | XXX | XXX | XXX |
| Gross Profit | $0.6M | $0.5M | XXX | XXX | XXX |
| Gross Margin | 8% | 8% | XXX | XXX | XXX |
| EBITDA | $2.2M | -$1.4M | XXX | XXX | XXX |
| EBITDA Margin | 26% | -24% | XXX | XXX | XXX |
| Net Profit | -$3.3M | $3.1M | XXX | XXX | XXX |
| Net Margin | -41% | 52% | XXX | XXX | XXX |
| Net Debt | $7.7M | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, SMAIO's stock price is EUR 4 (or $4).
SMAIO has current market cap of EUR 18.7M (or $20.1M), and EV of EUR 16.3M (or $17.5M).
See SMAIO trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $17.5M | $20.1M | XXX | XXX | XXX | XXX | $-0.28 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, SMAIO has market cap of $20.1M and EV of $17.5M.
SMAIO's trades at 2.4x LTM EV/Revenue multiple, and -31.1x LTM EBITDA.
Analysts estimate SMAIO's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for SMAIO and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $17.5M | XXX | XXX | XXX |
| EV/Revenue | 3.0x | XXX | XXX | XXX |
| EV/EBITDA | -12.5x | XXX | XXX | XXX |
| P/E | -8.9x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -4.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpSMAIO's NTM/LTM revenue growth is 61%
SMAIO's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, SMAIO's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate SMAIO's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for SMAIO and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -28% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -24% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -165% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 37% | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 59% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Alcidion Group | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
| Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
SMAIO acquired XXX companies to date.
Last acquisition by SMAIO was XXXXXXXX, XXXXX XXXXX XXXXXX . SMAIO acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| Where is SMAIO headquartered? | SMAIO is headquartered in France. |
| Is SMAIO publicy listed? | Yes, SMAIO is a public company listed on PAR. |
| What is the stock symbol of SMAIO? | SMAIO trades under ALSMA ticker. |
| When did SMAIO go public? | SMAIO went public in 2022. |
| Who are competitors of SMAIO? | Similar companies to SMAIO include e.g. Benevolent AI, Alcidion Group, CurveBeam AI, Doctor Care Anywhere. |
| What is the current market cap of SMAIO? | SMAIO's current market cap is $20.1M |
| What is the current revenue of SMAIO? | SMAIO's last 12-month revenue is $7.4M. |
| What is the current EBITDA of SMAIO? | SMAIO's last 12-month EBITDA is -$0.6M. |
| What is the current EV/Revenue multiple of SMAIO? | Current revenue multiple of SMAIO is 2.4x. |
| What is the current EV/EBITDA multiple of SMAIO? | Current EBITDA multiple of SMAIO is -31.1x. |
| What is the current revenue growth of SMAIO? | SMAIO revenue growth between 2023 and 2024 was -28%. |
| Is SMAIO profitable? | Yes, SMAIO is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
